Procambarus clarkii strain Jiangsu linkage group LG72, ASM2042438v2, whole genome shotgun sequence.
Procambarus clarkii (red swamp crayfish)
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Crustacea; Multicrustacea; Malacostraca; Eumalacostraca; Eucarida; Decapoda; Pleocyemata; Astacidea; Astacoidea; Cambaridae; Procambarus.
A chromosome-level reference genome of red swamp crayfish Procambarus clarkii provides insights into the gene families regarding growth or development in crustaceans
REFSEQ INFORMATION: The reference sequence is identical to\nCM035544.1.\nAssembly name: ASM2042438v2\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Freshwater Fisheries Research\nInstitute of Jiangsu Province, Nanjing 210017, China on 2021/10/12.\nThe original whole-genome shotgun project has the accession\nJAIWQB000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Freshwater Fisheries Research Institute\n of Jiangsu Province, Nanjing 210017,\n China\nAssembly Method :: LACHESIS v. may-2020\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 100.0x\nSequencing Technology :: PacBio RS\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Procambarus clarkii Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
COORDINATES: polyA evidence [ECO:0006239]
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
brahma-associated protein of 60 kDa-like
similar to RNA sequence (same species):INSD:GBEV01018364.1
annotated by transcript or proteomic data
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 144 bases not found in genome assembly
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 144 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
inhibitor of nuclear factor kappa-B kinase subunit epsilon-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 86 samples with support for all annotated introns
inhibitor of nuclear factor kappa-B kinase subunit epsilon-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
inhibitor of nuclear factor kappa-B kinase subunit epsilon-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
inhibitor of nuclear factor kappa-B kinase subunit epsilon-like isoform X1
inhibitor of nuclear factor kappa-B kinase subunit epsilon-like isoform X2
inhibitor of nuclear factor kappa-B kinase subunit epsilon-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
serine/threonine-protein kinase TBK1-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 80% coverage of the annotated genomic feature by RNAseq alignments
UDP-galactose transporter senju-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
UDP-galactose transporter senju-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
UDP-galactose transporter senju-like isoform X2
UDP-galactose transporter senju-like isoform X1
proline-rich receptor-like protein kinase PERK8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
beta-lactamase-like protein 2 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
beta-lactamase-like protein 2 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
beta-lactamase-like protein 2 homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 92% coverage of the annotated genomic feature by RNAseq alignments
DNA-directed RNA polymerase II subunit RPB9-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 80% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC123773113, transcript variant X3
uncharacterized LOC123773113, transcript variant X2
uncharacterized protein LOC123773113 isoform X2
uncharacterized LOC123773113, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC123773113, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized protein LOC123773113 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 49 samples with support for all annotated introns
receptor-type tyrosine-protein phosphatase H-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
receptor-type tyrosine-protein phosphatase H-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
receptor-type tyrosine-protein phosphatase H-like, transcript variant X1
receptor-type tyrosine-protein phosphatase H-like, transcript variant X3
receptor-type tyrosine-protein phosphatase H-like isoform X3
receptor-type tyrosine-protein phosphatase H-like isoform X2
receptor-type tyrosine-protein phosphatase H-like isoform X1
ciliary rootlet coiled-coil protein 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12% coverage of the annotated genomic feature by RNAseq alignments
tyrosine-protein kinase receptor Tie-1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 65% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA tryptophan (anticodon CCA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA threonine (anticodon CGU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins
probable serine/threonine-protein kinase fnkE
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 84% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 58 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC123773122, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized protein LOC123773122 isoform X1
uncharacterized LOC123773122, transcript variant X2
uncharacterized protein LOC123773122 isoform X2
uncharacterized LOC123773122, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
uncharacterized protein LOC123773122 isoform X3
ring-infected erythrocyte surface antigen-like
SRSF protein kinase 1-like, transcript variant X3
SRSF protein kinase 1-like, transcript variant X2
SRSF protein kinase 1-like, transcript variant X1
uncharacterized protein LOC123773120 isoform X1
uncharacterized protein LOC123773120 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments
laminin subunit alpha-1-like, transcript variant X1
laminin subunit alpha-1-like, transcript variant X3
laminin subunit alpha-1-like, transcript variant X2
laminin subunit alpha-1-like, transcript variant X4
sphingolipid delta(4)-desaturase DES1-like, transcript variant X3
sphingolipid delta(4)-desaturase DES1-like isoform X3
sphingolipid delta(4)-desaturase DES1-like, transcript variant X2
sphingolipid delta(4)-desaturase DES1-like isoform X2
sphingolipid delta(4)-desaturase DES1-like, transcript variant X1
sphingolipid delta(4)-desaturase DES1-like isoform X1
uncharacterized LOC123773129, transcript variant X2
uncharacterized LOC123773129, transcript variant X1
probable phosphorylase b kinase regulatory subunit beta, transcript variant X3
probable phosphorylase b kinase regulatory subunit beta isoform X3
probable phosphorylase b kinase regulatory subunit beta, transcript variant X4
probable phosphorylase b kinase regulatory subunit beta, transcript variant X2
probable phosphorylase b kinase regulatory subunit beta, transcript variant X1
probable phosphorylase b kinase regulatory subunit beta, transcript variant X5
probable phosphorylase b kinase regulatory subunit beta, transcript variant X6
probable phosphorylase b kinase regulatory subunit beta isoform X4
probable phosphorylase b kinase regulatory subunit beta isoform X2
probable phosphorylase b kinase regulatory subunit beta isoform X1
probable phosphorylase b kinase regulatory subunit beta isoform X5
probable phosphorylase b kinase regulatory subunit beta isoform X6
gelsolin, cytoplasmic-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
gelsolin, cytoplasmic-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
gelsolin, cytoplasmic-like, transcript variant X1
gelsolin, cytoplasmic-like, transcript variant X5
gelsolin, cytoplasmic-like, transcript variant X2
gelsolin, cytoplasmic-like, transcript variant X6
ecotropic viral integration site 5 ortholog-like
similar to RNA sequence (same species):INSD:GARH01011767.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 363 bases not found in genome assembly
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 363 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
cleavage and polyadenylation specificity factor subunit 1-like
uncharacterized LOC123773137, transcript variant X4
uncharacterized LOC123773137, transcript variant X7
uncharacterized LOC123773137, transcript variant X5
uncharacterized LOC123773137, transcript variant X3
uncharacterized LOC123773137, transcript variant X1
uncharacterized LOC123773137, transcript variant X6
uncharacterized LOC123773137, transcript variant X2
uncharacterized protein LOC123773137 isoform X1
uncharacterized protein LOC123773137 isoform X2
uncharacterized protein LOC123773137 isoform X3
similar to RNA sequence (same species):INSD:GBEV01026349.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 1260 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 1260 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
galactose-3-O-sulfotransferase 2-like, transcript variant X3
galactose-3-O-sulfotransferase 2-like, transcript variant X2
galactose-3-O-sulfotransferase 2-like, transcript variant X1
nuclear protein localization protein 4 homolog
trichohyalin-like, transcript variant X1
trichohyalin-like, transcript variant X2
U6 snRNA-associated Sm-like protein LSm3
chromatin accessibility complex protein 1-like
protein OPI10 homolog, transcript variant X1
protein OPI10 homolog, transcript variant X2
galactosylceramide sulfotransferase-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 63% coverage of the annotated genomic feature by RNAseq alignments
N-acetylglucosamine-6-phosphate deacetylase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 56 samples with support for all annotated introns
N-acetylglucosamine-6-phosphate deacetylase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
N-acetylglucosamine-6-phosphate deacetylase-like
heparan sulfate 2-O-sulfotransferase pipe-like
receptor-type tyrosine-protein phosphatase mu-like
lisH domain-containing protein C1711.05-like
uncharacterized LOC123773148, transcript variant X2
uncharacterized LOC123773148, transcript variant X1
uncharacterized LOC123773148, transcript variant X3
uncharacterized LOC123773148, transcript variant X4
sodium-coupled neutral amino acid transporter 9-like, transcript variant X2
sodium-coupled neutral amino acid transporter 9-like, transcript variant X5
nucleolar protein dao-5-like, transcript variant X4
nucleolar protein dao-5-like, transcript variant X1
nucleolar protein dao-5-like, transcript variant X2
nucleolar protein dao-5-like, transcript variant X3
transfer RNA threonine (anticodon AGU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
sodium-coupled neutral amino acid transporter 9-like, transcript variant X3
sodium-coupled neutral amino acid transporter 9-like, transcript variant X1
sodium-coupled neutral amino acid transporter 9-like, transcript variant X4
sodium-coupled neutral amino acid transporter 9-like
uncharacterized LOC123773153, transcript variant X2
uncharacterized LOC123773153, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 46 samples with support for all annotated introns
snRNA-activating protein complex subunit 3-like, transcript variant X2
snRNA-activating protein complex subunit 3-like, transcript variant X1
snRNA-activating protein complex subunit 3-like isoform X1
snRNA-activating protein complex subunit 3-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized protein LOC123773155 isoform X2
putative phosphatidate phosphatase, transcript variant X2
putative phosphatidate phosphatase, transcript variant X1
putative phosphatidate phosphatase, transcript variant X4
putative phosphatidate phosphatase isoform X2
phospholipid phosphatase 3-like isoform X1
phospholipid phosphatase 3-like isoform X4
putative phosphatidate phosphatase, transcript variant X3
phospholipid phosphatase 1-like isoform X3
oxysterol-binding protein-related protein 8-like, transcript variant X8
oxysterol-binding protein-related protein 8-like, transcript variant X3
oxysterol-binding protein-related protein 8-like, transcript variant X7
oxysterol-binding protein-related protein 8-like, transcript variant X4
oxysterol-binding protein-related protein 8-like, transcript variant X5
oxysterol-binding protein-related protein 8-like isoform X3
oxysterol-binding protein-related protein 8-like isoform X6
oxysterol-binding protein-related protein 8-like isoform X7
oxysterol-binding protein-related protein 8-like isoform X4
oxysterol-binding protein-related protein 8-like, transcript variant X6
oxysterol-binding protein-related protein 8-like isoform X5
oxysterol-binding protein-related protein 8-like, transcript variant X2
oxysterol-binding protein-related protein 8-like, transcript variant X1
oxysterol-binding protein-related protein 8-like isoform X1
oxysterol-binding protein-related protein 8-like isoform X2
oxysterol-binding protein-related protein 8-like, transcript variant X9
oxysterol-binding protein-related protein 8-like, transcript variant X10
oxysterol-binding protein-related protein 8-like isoform X8
oxysterol-binding protein-related protein 8-like isoform X9
oxysterol-binding protein-related protein 8-like, transcript variant X12
oxysterol-binding protein-related protein 8-like, transcript variant X11
oxysterol-binding protein-related protein 8-like isoform X10
oxysterol-binding protein-related protein 8-like isoform X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 98% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
receptor-type tyrosine-protein phosphatase epsilon-like, transcript variant X1
receptor-type tyrosine-protein phosphatase epsilon-like, transcript variant X2
receptor-type tyrosine-protein phosphatase epsilon-like, transcript variant X3
receptor-type tyrosine-protein phosphatase epsilon-like isoform X1
receptor-type tyrosine-protein phosphatase epsilon-like isoform X2
receptor-type tyrosine-protein phosphatase epsilon-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 93% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
similar to RNA sequence (same species):INSD:GARH01040954.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 263 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 263 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
uncharacterized histidine-rich protein DDB_G0274557-like
MAPK regulated corepressor interacting protein 2-like
histidine--tRNA ligase-like, transcript variant X7
histidine--tRNA ligase-like, transcript variant X1
histidine--tRNA ligase-like, transcript variant X8
histidine--tRNA ligase-like, transcript variant X5
histidine--tRNA ligase-like, transcript variant X2
histidine--tRNA ligase-like, transcript variant X9
histidine--tRNA ligase-like, transcript variant X10
histidine--tRNA ligase-like, transcript variant X3
histidine--tRNA ligase-like, transcript variant X4
histidine--tRNA ligase-like, transcript variant X6
uncharacterized protein C1orf50 homolog, transcript variant X1
uncharacterized protein C1orf50 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
hepatocyte nuclear factor 4-gamma-like, transcript variant X1
hepatocyte nuclear factor 4-gamma-like, transcript variant X3
hepatocyte nuclear factor 4-gamma-like, transcript variant X4
hepatocyte nuclear factor 4-gamma-like, transcript variant X5
hepatocyte nuclear factor 4-gamma-like, transcript variant X2
hepatocyte nuclear factor 4-gamma-like isoform X1
hepatocyte nuclear factor 4-gamma-like isoform X2
hepatocyte nuclear factor 4-gamma-like isoform X3
hepatocyte nuclear factor 4-gamma-like isoform X4
argininosuccinate synthase-like, transcript variant X1
argininosuccinate synthase-like, transcript variant X2
uncharacterized LOC123773178, transcript variant X19
uncharacterized LOC123773178, transcript variant X26
uncharacterized LOC123773178, transcript variant X21
uncharacterized LOC123773178, transcript variant X14
uncharacterized LOC123773178, transcript variant X13
uncharacterized LOC123773178, transcript variant X12
uncharacterized LOC123773178, transcript variant X5
uncharacterized LOC123773178, transcript variant X10
uncharacterized LOC123773178, transcript variant X6
uncharacterized LOC123773178, transcript variant X44
uncharacterized LOC123773178, transcript variant X50
uncharacterized LOC123773178, transcript variant X49
uncharacterized LOC123773178, transcript variant X42
uncharacterized LOC123773178, transcript variant X48
uncharacterized LOC123773178, transcript variant X45
uncharacterized LOC123773178, transcript variant X20
uncharacterized LOC123773178, transcript variant X37
uncharacterized LOC123773178, transcript variant X11
uncharacterized LOC123773178, transcript variant X23
uncharacterized LOC123773178, transcript variant X28
uncharacterized LOC123773178, transcript variant X33
uncharacterized LOC123773178, transcript variant X18
uncharacterized LOC123773178, transcript variant X3
uncharacterized LOC123773178, transcript variant X39
uncharacterized LOC123773178, transcript variant X22
uncharacterized LOC123773178, transcript variant X29
uncharacterized LOC123773178, transcript variant X46
uncharacterized LOC123773178, transcript variant X15
uncharacterized LOC123773178, transcript variant X27
uncharacterized LOC123773178, transcript variant X43
uncharacterized LOC123773178, transcript variant X8
uncharacterized LOC123773178, transcript variant X40
uncharacterized LOC123773178, transcript variant X47
uncharacterized LOC123773178, transcript variant X38
uncharacterized LOC123773178, transcript variant X2
uncharacterized LOC123773178, transcript variant X41
uncharacterized LOC123773178, transcript variant X32
uncharacterized LOC123773178, transcript variant X25
uncharacterized LOC123773178, transcript variant X36
uncharacterized LOC123773178, transcript variant X35
uncharacterized LOC123773178, transcript variant X31
uncharacterized LOC123773178, transcript variant X30
uncharacterized LOC123773178, transcript variant X24
uncharacterized LOC123773178, transcript variant X34
uncharacterized LOC123773178, transcript variant X17
uncharacterized LOC123773178, transcript variant X9
uncharacterized LOC123773178, transcript variant X7
uncharacterized LOC123773178, transcript variant X16
uncharacterized LOC123773178, transcript variant X4
uncharacterized LOC123773178, transcript variant X1
uncharacterized protein LOC123773178 isoform X10
uncharacterized protein LOC123773178 isoform X6
uncharacterized protein LOC123773178 isoform X44
uncharacterized protein LOC123773178 isoform X50
uncharacterized protein LOC123773178 isoform X49
uncharacterized protein LOC123773178 isoform X42
uncharacterized protein LOC123773178 isoform X48
uncharacterized protein LOC123773178 isoform X45
uncharacterized protein LOC123773178 isoform X20
uncharacterized protein LOC123773178 isoform X37
uncharacterized protein LOC123773178 isoform X11
uncharacterized protein LOC123773178 isoform X23
uncharacterized protein LOC123773178 isoform X28
uncharacterized protein LOC123773178 isoform X33
uncharacterized protein LOC123773178 isoform X18
uncharacterized protein LOC123773178 isoform X3
uncharacterized protein LOC123773178 isoform X39
uncharacterized protein LOC123773178 isoform X22
uncharacterized protein LOC123773178 isoform X29
uncharacterized protein LOC123773178 isoform X46
uncharacterized protein LOC123773178 isoform X15
uncharacterized protein LOC123773178 isoform X27
uncharacterized protein LOC123773178 isoform X43
uncharacterized protein LOC123773178 isoform X8
uncharacterized protein LOC123773178 isoform X40
uncharacterized protein LOC123773178 isoform X19
uncharacterized protein LOC123773178 isoform X47
uncharacterized protein LOC123773178 isoform X38
uncharacterized protein LOC123773178 isoform X2
uncharacterized protein LOC123773178 isoform X41
uncharacterized protein LOC123773178 isoform X32
uncharacterized protein LOC123773178 isoform X26
uncharacterized protein LOC123773178 isoform X21
uncharacterized protein LOC123773178 isoform X14
uncharacterized protein LOC123773178 isoform X13
uncharacterized protein LOC123773178 isoform X25
uncharacterized protein LOC123773178 isoform X12
uncharacterized protein LOC123773178 isoform X5
uncharacterized protein LOC123773178 isoform X36
uncharacterized protein LOC123773178 isoform X35
uncharacterized protein LOC123773178 isoform X31
uncharacterized protein LOC123773178 isoform X30
uncharacterized protein LOC123773178 isoform X24
uncharacterized protein LOC123773178 isoform X34
uncharacterized protein LOC123773178 isoform X17
uncharacterized protein LOC123773178 isoform X9
uncharacterized protein LOC123773178 isoform X7
uncharacterized protein LOC123773178 isoform X16
uncharacterized protein LOC123773178 isoform X4
uncharacterized protein LOC123773178 isoform X1
uncharacterized LOC123773184, transcript variant X6
uncharacterized LOC123773184, transcript variant X12
uncharacterized LOC123773184, transcript variant X9
uncharacterized LOC123773184, transcript variant X11
uncharacterized LOC123773184, transcript variant X5
uncharacterized LOC123773184, transcript variant X10
uncharacterized LOC123773184, transcript variant X7
uncharacterized LOC123773184, transcript variant X2
uncharacterized LOC123773184, transcript variant X8
uncharacterized LOC123773184, transcript variant X3
uncharacterized LOC123773184, transcript variant X4
uncharacterized LOC123773184, transcript variant X1
uncharacterized protein LOC123773184 isoform X6
uncharacterized protein LOC123773184 isoform X12
uncharacterized protein LOC123773184 isoform X9
uncharacterized protein LOC123773184 isoform X11
uncharacterized protein LOC123773184 isoform X5
uncharacterized protein LOC123773184 isoform X10
uncharacterized protein LOC123773184 isoform X7
uncharacterized protein LOC123773184 isoform X2
uncharacterized protein LOC123773184 isoform X8
uncharacterized protein LOC123773184 isoform X3
uncharacterized protein LOC123773184 isoform X4
uncharacterized protein LOC123773184 isoform X1
cytochrome P450 2L1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 76 samples with support for all annotated introns
cytochrome P450 2L1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC123773187, transcript variant X2
uncharacterized LOC123773187, transcript variant X1
host cell factor 2-like, transcript variant X2
host cell factor 2-like, transcript variant X1
N-fatty-acyl-amino acid synthase/hydrolase PM20D1-like, transcript variant X5
N-fatty-acyl-amino acid synthase/hydrolase PM20D1-like, transcript variant X8
N-fatty-acyl-amino acid synthase/hydrolase PM20D1-like, transcript variant X7
N-fatty-acyl-amino acid synthase/hydrolase PM20D1-like, transcript variant X6
N-fatty-acyl-amino acid synthase/hydrolase PM20D1-like, transcript variant X9
N-fatty-acyl-amino acid synthase/hydrolase PM20D1-like, transcript variant X2
N-fatty-acyl-amino acid synthase/hydrolase PM20D1-like, transcript variant X1
N-fatty-acyl-amino acid synthase/hydrolase PM20D1-like, transcript variant X3
N-fatty-acyl-amino acid synthase/hydrolase PM20D1-like, transcript variant X4
N-fatty-acyl-amino acid synthase/hydrolase PM20D1-like isoform X3
N-fatty-acyl-amino acid synthase/hydrolase PM20D1-like isoform X1
N-fatty-acyl-amino acid synthase/hydrolase PM20D1-like isoform X2
coiled-coil domain-containing protein 8 homolog
E3 ubiquitin-protein ligase LRSAM1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
E3 ubiquitin-protein ligase LRSAM1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
E3 ubiquitin-protein ligase LRSAM1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 78 samples with support for all annotated introns
E3 ubiquitin-protein ligase LRSAM1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 44 samples with support for all annotated introns
uncharacterized protein in mobD 3'region-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins
uncharacterized LOC123773199, transcript variant X17
similar to RNA sequence (same species):INSD:GARH01035778.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 492 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC123773199, transcript variant X16
uncharacterized LOC123773199, transcript variant X4
uncharacterized LOC123773199, transcript variant X3
uncharacterized LOC123773199, transcript variant X5
uncharacterized LOC123773199, transcript variant X13
uncharacterized LOC123773199, transcript variant X10
uncharacterized LOC123773199, transcript variant X7
uncharacterized LOC123773199, transcript variant X12
uncharacterized LOC123773199, transcript variant X9
uncharacterized LOC123773199, transcript variant X2
uncharacterized LOC123773199, transcript variant X11
uncharacterized LOC123773199, transcript variant X8
uncharacterized LOC123773199, transcript variant X6
uncharacterized LOC123773199, transcript variant X1
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 273 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
uncharacterized protein LOC123773199 isoform X17
uncharacterized protein LOC123773199 isoform X16
uncharacterized protein LOC123773199 isoform X4
uncharacterized protein LOC123773199 isoform X3
uncharacterized protein LOC123773199 isoform X5
uncharacterized protein LOC123773199 isoform X13
uncharacterized protein LOC123773199 isoform X10
uncharacterized protein LOC123773199 isoform X7
uncharacterized protein LOC123773199 isoform X12
uncharacterized protein LOC123773199 isoform X9
uncharacterized protein LOC123773199 isoform X2
uncharacterized protein LOC123773199 isoform X11
uncharacterized protein LOC123773199 isoform X8
uncharacterized protein LOC123773199 isoform X6
uncharacterized protein LOC123773199 isoform X1
uncharacterized LOC123773199, transcript variant X15
uncharacterized LOC123773199, transcript variant X14
uncharacterized protein LOC123773199 isoform X15
uncharacterized protein LOC123773199 isoform X14
T-box transcription factor T-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
T-box transcription factor T-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
T-box transcription factor T-like isoform X1
T-box transcription factor T-like isoform X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: T-box transcription factor T-like
MAP kinase-activating death domain protein-like
RFX-like DNA-binding protein RFX1, transcript variant X1
RFX-like DNA-binding protein RFX1, transcript variant X2
RFX-like DNA-binding protein RFX1, transcript variant X3
RFX-like DNA-binding protein RFX1, transcript variant X4
RFX-like DNA-binding protein RFX1, transcript variant X5
uncharacterized protein LOC123772978 isoform X1
uncharacterized protein LOC123772978 isoform X2
uncharacterized protein LOC123772978 isoform X3
RFX-like DNA-binding protein RFX1 isoform X4
uncharacterized LOC123772977, transcript variant X2
uncharacterized LOC123772977, transcript variant X1
uncharacterized protein LOC123772977 isoform X1
uncharacterized protein LOC123772977 isoform X2
transient receptor potential channel pyrexia-like
transient receptor potential channel pyrexia-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
transient receptor potential channel pyrexia-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
transient receptor potential channel pyrexia-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
transient receptor potential channel pyrexia-like, transcript variant X1
uncharacterized protein LOC123772974 isoform X3
uncharacterized protein LOC123772974 isoform X2
transient receptor potential channel pyrexia-like isoform X1
transient receptor potential channel pyrexia-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
AP-4 complex subunit epsilon-1-like, transcript variant X6
AP-4 complex subunit epsilon-1-like, transcript variant X5
AP-4 complex subunit epsilon-1-like, transcript variant X4
AP-4 complex subunit epsilon-1-like, transcript variant X2
AP-4 complex subunit epsilon-1-like, transcript variant X3
AP-4 complex subunit epsilon-1-like, transcript variant X1
protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha-like, transcript variant X5
protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha-like, transcript variant X4
protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha-like, transcript variant X1
protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha-like, transcript variant X2
protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha-like isoform X1
protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha-like isoform X2
protein FAM107B-like, transcript variant X6
protein FAM107B-like, transcript variant X1
protein FAM107B-like, transcript variant X5
protein FAM107B-like, transcript variant X2
protein FAM107B-like, transcript variant X7
protein FAM107B-like, transcript variant X4
protein FAM107B-like, transcript variant X3
uncharacterized LOC123772987, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC123772987, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 57 samples with support for all annotated introns
dual serine/threonine and tyrosine protein kinase-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 70% coverage of the annotated genomic feature by RNAseq alignments
amiloride-sensitive sodium channel subunit alpha-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 91% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 80% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 95% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
thioredoxin domain-containing protein 9-like, transcript variant X1
thioredoxin domain-containing protein 9-like, transcript variant X2
thioredoxin domain-containing protein 9-like
uncharacterized LOC123772994, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
uncharacterized LOC123772994, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 71 samples with support for all annotated introns
uncharacterized LOC123772994, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 93 samples with support for all annotated introns
uncharacterized LOC123772994, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized LOC123772994, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 83 samples with support for all annotated introns
uncharacterized LOC123772994, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 63 samples with support for all annotated introns
uncharacterized LOC123772994, transcript variant X8
uncharacterized LOC123772994, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 52 samples with support for all annotated introns
uncharacterized protein LOC123772994 isoform X1
uncharacterized protein LOC123772994 isoform X2
uncharacterized protein LOC123772994 isoform X3
uncharacterized LOC123772995, transcript variant X1
uncharacterized LOC123772995, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC123772995, transcript variant X3
uncharacterized protein LOC123772995 isoform X1
uncharacterized protein LOC123772995 isoform X2
uncharacterized protein LOC123772995 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins
cyclin-dependent kinase 9-like, transcript variant X2
cyclin-dependent kinase 9-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
cyclin-dependent kinase 9-like isoform X1
cyclin-dependent kinase 9-like isoform X2
methionine--tRNA ligase, mitochondrial-like, transcript variant X1
methionine--tRNA ligase, mitochondrial-like, transcript variant X3
methionine--tRNA ligase, mitochondrial-like, transcript variant X2
methionine--tRNA ligase, mitochondrial-like, transcript variant X4
methionine--tRNA ligase, mitochondrial-like
threonylcarbamoyladenosine tRNA methylthiotransferase-like, transcript variant X1
threonylcarbamoyladenosine tRNA methylthiotransferase-like, transcript variant X2
threonylcarbamoyladenosine tRNA methylthiotransferase-like, transcript variant X3
threonylcarbamoyladenosine tRNA methylthiotransferase-like, transcript variant X4
threonylcarbamoyladenosine tRNA methylthiotransferase-like
tetraspanin-31-like, transcript variant X1
tetraspanin-31-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha-like
reticulophagy regulator 3-like, transcript variant X1
reticulophagy regulator 3-like, transcript variant X2
reticulophagy regulator 3-like isoform X1
reticulophagy regulator 2-like isoform X2
tyrosine-protein phosphatase non-receptor type 23-like, transcript variant X2
tyrosine-protein phosphatase non-receptor type 23-like, transcript variant X3
tyrosine-protein phosphatase non-receptor type 23-like, transcript variant X4
tyrosine-protein phosphatase non-receptor type 23-like, transcript variant X1
tyrosine-protein phosphatase non-receptor type 23-like isoform X2
tyrosine-protein phosphatase non-receptor type 23-like isoform X3
tyrosine-protein phosphatase non-receptor type 23-like isoform X4
tyrosine-protein phosphatase non-receptor type 23-like isoform X1
E3 ubiquitin-protein ligase RNF14-like, transcript variant X4
E3 ubiquitin-protein ligase RNF14-like, transcript variant X3
E3 ubiquitin-protein ligase RNF14-like, transcript variant X2
E3 ubiquitin-protein ligase RNF14-like, transcript variant X1
E3 ubiquitin-protein ligase RNF14-like isoform X2
E3 ubiquitin-protein ligase RNF14-like isoform X1
E3 ubiquitin-protein ligase RNF14-like isoform X3
importin subunit alpha-1a-like, transcript variant X1
importin subunit alpha-1a-like, transcript variant X2
importin subunit alpha-1a-like, transcript variant X3
importin subunit alpha-1a-like, transcript variant X4
importin subunit alpha-1a-like, transcript variant X5
importin subunit alpha-1a-like, transcript variant X6
importin subunit alpha-1a-like isoform X1
importin subunit alpha-1a-like isoform X2
importin subunit alpha-1a-like isoform X3
importin subunit alpha-1a-like isoform X4
importin subunit alpha-1a-like isoform X5
importin subunit alpha-1a-like isoform X6
importin subunit alpha-3-like, transcript variant X1
importin subunit alpha-3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
exocyst complex component 5-like, transcript variant X2
exocyst complex component 5-like, transcript variant X1
aldehyde dehydrogenase, dimeric NADP-preferring-like, transcript variant X3
aldehyde dehydrogenase, dimeric NADP-preferring-like, transcript variant X6
aldehyde dehydrogenase, dimeric NADP-preferring-like, transcript variant X1
aldehyde dehydrogenase, dimeric NADP-preferring-like, transcript variant X2
aldehyde dehydrogenase, dimeric NADP-preferring-like, transcript variant X5
aldehyde dehydrogenase, dimeric NADP-preferring-like, transcript variant X4
aldehyde dehydrogenase, dimeric NADP-preferring-like isoform X4
aldehyde dehydrogenase, dimeric NADP-preferring-like isoform X3
aldehyde dehydrogenase, dimeric NADP-preferring-like isoform X1
aldehyde dehydrogenase, dimeric NADP-preferring-like isoform X2
F-box/WD repeat-containing protein 7-like
similar to RNA sequence (same species):INSD:GBEV01006647.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 2344 bases not found in genome assembly
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 1943 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
probable phospholipid-transporting ATPase IA
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC123773022, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 89 samples with support for all annotated introns
uncharacterized LOC123773022, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 88 samples with support for all annotated introns
uncharacterized protein LOC123773022 isoform X1
uncharacterized protein LOC123773022 isoform X3
uncharacterized LOC123773022, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC123773022, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
uncharacterized protein LOC123773022 isoform X2
phosphatidylinositol 4-kinase beta-like, transcript variant X2
phosphatidylinositol 4-kinase beta-like, transcript variant X4
phosphatidylinositol 4-kinase beta-like, transcript variant X1
phosphatidylinositol 4-kinase beta-like, transcript variant X5
phosphatidylinositol 4-kinase beta-like, transcript variant X3
transfer RNA glutamine (anticodon CUG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA glutamine (anticodon UUG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
breast cancer metastasis-suppressor 1-like protein, transcript variant X2
breast cancer metastasis-suppressor 1-like protein, transcript variant X1
breast cancer metastasis-suppressor 1-like protein, transcript variant X3
breast cancer metastasis-suppressor 1-like protein isoform X1
breast cancer metastasis-suppressor 1-like protein isoform X2